Loading…
Injecto Polymers (BSE 544930)₹95.75+0.92%Packaging
For the year to Mar 2026, sales were ₹375 Cr and net profit ₹16.05 Cr.
Company filings, standalone accounts
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Sales | 48.91 | 87.80 | 95.84 | 109 | 261 | 375 |
| Expenses | 44.09 | 81.08 | 88.10 | 97.15 | 239 | 338 |
| Operating Profit | 5.01 | 6.01 | 8.01 | 12.01 | 23.04 | 38.09 |
| OPM % | 9.0% | 7.0% | 8.0% | 11.0% | 9.0% | 10.1% |
| Other Income | 0.00 | 2.01 | 0.00 | 1.01 | 0.00 | 1.01 |
| Interest | 2.99 | 4.99 | 4.99 | 5.99 | 8.99 | 11.98 |
| Depreciation | 0.99 | 0.99 | 1.99 | 1.99 | 1.99 | 2.99 |
| Profit before tax | 1.01 | 1.01 | 1.01 | 5.01 | 11.03 | 23.07 |
| Tax % | −75.0% | 14.9% | −56.0% | 9.9% | 28.0% | 32.0% |
| Net Profit | 1.01 | 1.01 | 2.01 | 4.01 | 8.02 | 16.05 |
| EPS (Rs) | 15.75 | 12.54 | 17.63 | 3.31 | 5.33 | 10.53 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Equity Capital | 9.00 | 9.01 | 12.02 | 13.02 | 15.01 | 15.01 |
| Reserves | 2.00 | 2.99 | 5.99 | 8.00 | 31.98 | 47.96 |
| Borrowings | 28.98 | 56.88 | 63.82 | 82.92 | 101 | 165 |
| Other Liabilities | 15.07 | 20.10 | 27.12 | 17.08 | 22.11 | 42.20 |
| Total Liabilities | 55.05 | 88.98 | 108 | 121 | 171 | 271 |
| Fixed Assets | 15.04 | 33.06 | 32.04 | 33.03 | 41.04 | 42.06 |
| CWIP | 13.02 | 0.00 | 2.01 | 2.01 | 2.01 | 1.01 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 26.99 | 55.92 | 73.90 | 85.98 | 128 | 228 |
| Inventories | 6.01 | 21.02 | 36.04 | 40.01 | 74.04 | 140 |
| Trade receivables | 16.04 | 28.08 | 30.10 | 31.07 | 36.09 | 64.17 |
| Cash & equivalents | 0.00 | 1.01 | 1.99 | 2.99 | 7.01 | 6.99 |
| Total Assets | 55.05 | 88.98 | 108 | 121 | 171 | 271 |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Cash from operating activity | 9.96 | −15.92 | −1.99 | −12.94 | −16.93 | −48.82 |
| Cash from investing activity | −10.96 | −5.98 | −2.99 | −2.99 | −8.97 | −2.99 |
| Cash from financing activity | 1.01 | 22.09 | 5.02 | 16.06 | 26.09 | 52.14 |
| Net cash flow | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Capex | 0.02 | 19.17 | 1.15 | 2.84 | 10.05 | 4.24 |
| Free cash flow | −0.99 | −21.95 | −4.99 | −15.96 | −25.92 | −51.84 |
| CFO / OP % | 228.1% | −257.9% | −29.0% | −103.0% | −71.0% | −123.9% |
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|
| Debtor days | 123 | 118 | 116 | 106 | 51 | 63 |
| Inventory days | 54 | 105 | 167 | 175 | 126 | 165 |
| Days payable | 104 | 92 | 125 | 56 | 26 | 34 |
| Cash conversion cycle | 71 | 129 | 156 | 223 | 148 | 193 |
| Working capital days | 20 | 109 | 42 | 53 | 21 | 24 |
| ROCE % | — | 12.0% | 9.0% | 12.0% | 16.0% | 19.0% |
Injecto Polymers' sales for the year to Mar 2026 were ₹375 Cr.
Net profit for the year to Mar 2026 was ₹16.05 Cr. Earnings per share over the same trailing period were ₹10.53.
Injecto Polymers reported borrowings of ₹165 Cr at Mar 2026, against cash and equivalents of ₹6.99 Cr.
Cash from operations was −₹48.82 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹51.84 Cr.